237 related articles for article (PubMed ID: 20197042)
1. Left-handed dimer of EphA2 transmembrane domain: Helix packing diversity among receptor tyrosine kinases.
Bocharov EV; Mayzel ML; Volynsky PE; Mineev KS; Tkach EN; Ermolyuk YS; Schulga AA; Efremov RG; Arseniev AS
Biophys J; 2010 Mar; 98(5):881-9. PubMed ID: 20197042
[TBL] [Abstract][Full Text] [Related]
2. Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase EphA1.
Bocharov EV; Mayzel ML; Volynsky PE; Goncharuk MV; Ermolyuk YS; Schulga AA; Artemenko EO; Efremov RG; Arseniev AS
J Biol Chem; 2008 Oct; 283(43):29385-95. PubMed ID: 18728013
[TBL] [Abstract][Full Text] [Related]
3. Point mutations in dimerization motifs of the transmembrane domain stabilize active or inactive state of the EphA2 receptor tyrosine kinase.
Sharonov GV; Bocharov EV; Kolosov PM; Astapova MV; Arseniev AS; Feofanov AV
J Biol Chem; 2014 May; 289(21):14955-64. PubMed ID: 24733396
[TBL] [Abstract][Full Text] [Related]
4. Insights into the Packing Switching of the EphA2 Transmembrane Domain by Molecular Dynamic Simulations.
Sun F; Xu L; Chen P; Wei P; Qu J; Chen J; Luo SZ
J Phys Chem B; 2015 Jun; 119(25):7816-24. PubMed ID: 26022644
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics simulations of the dimerization of transmembrane alpha-helices.
Psachoulia E; Marshall DP; Sansom MS
Acc Chem Res; 2010 Mar; 43(3):388-96. PubMed ID: 20017540
[TBL] [Abstract][Full Text] [Related]
6. Spatial structure of the dimeric transmembrane domain of the growth factor receptor ErbB2 presumably corresponding to the receptor active state.
Bocharov EV; Mineev KS; Volynsky PE; Ermolyuk YS; Tkach EN; Sobol AG; Chupin VV; Kirpichnikov MP; Efremov RG; Arseniev AS
J Biol Chem; 2008 Mar; 283(11):6950-6. PubMed ID: 18178548
[TBL] [Abstract][Full Text] [Related]
7. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.
Mineev KS; Bocharov EV; Pustovalova YE; Bocharova OV; Chupin VV; Arseniev AS
J Mol Biol; 2010 Jul; 400(2):231-43. PubMed ID: 20471394
[TBL] [Abstract][Full Text] [Related]
8. Architecture of Eph receptor clusters.
Himanen JP; Yermekbayeva L; Janes PW; Walker JR; Xu K; Atapattu L; Rajashankar KR; Mensinga A; Lackmann M; Nikolov DB; Dhe-Paganon S
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10860-5. PubMed ID: 20505120
[TBL] [Abstract][Full Text] [Related]
9. Structural and thermodynamic insight into the process of "weak" dimerization of the ErbB4 transmembrane domain by solution NMR.
Bocharov EV; Mineev KS; Goncharuk MV; Arseniev AS
Biochim Biophys Acta; 2012 Sep; 1818(9):2158-70. PubMed ID: 22579757
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane helix packing of ErbB/Neu receptor in membrane environment: a molecular dynamics study.
Aller P; Garnier N; Genest M
J Biomol Struct Dyn; 2006 Dec; 24(3):209-28. PubMed ID: 17054379
[TBL] [Abstract][Full Text] [Related]
11. A helix heterodimer in a lipid bilayer: prediction of the structure of an integrin transmembrane domain via multiscale simulations.
Kalli AC; Hall BA; Campbell ID; Sansom MS
Structure; 2011 Oct; 19(10):1477-84. PubMed ID: 22000516
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of the signal transduction via transmembrane domain of the human growth hormone receptor.
Bocharov EV; Lesovoy DM; Bocharova OV; Urban AS; Pavlov KV; Volynsky PE; Efremov RG; Arseniev AS
Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1410-1420. PubMed ID: 29571748
[TBL] [Abstract][Full Text] [Related]
13. NMR-based approach to measure the free energy of transmembrane helix-helix interactions.
Mineev KS; Lesovoy DM; Usmanova DR; Goncharuk SA; Shulepko MA; Lyukmanova EN; Kirpichnikov MP; Bocharov EV; Arseniev AS
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):164-72. PubMed ID: 24036227
[TBL] [Abstract][Full Text] [Related]
14. Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex.
Himanen JP; Goldgur Y; Miao H; Myshkin E; Guo H; Buck M; Nguyen M; Rajashankar KR; Wang B; Nikolov DB
EMBO Rep; 2009 Jul; 10(7):722-8. PubMed ID: 19525919
[TBL] [Abstract][Full Text] [Related]
15. Dimerization of the EphA1 receptor tyrosine kinase transmembrane domain: Insights into the mechanism of receptor activation.
Chavent M; Chetwynd AP; Stansfeld PJ; Sansom MS
Biochemistry; 2014 Oct; 53(42):6641-52. PubMed ID: 25286141
[TBL] [Abstract][Full Text] [Related]
16. Structural and Functional Insights into the Transmembrane Domain Association of Eph Receptors.
Sahoo AR; Buck M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445298
[TBL] [Abstract][Full Text] [Related]
17. The SAM domain inhibits EphA2 interactions in the plasma membrane.
Singh DR; Ahmed F; Paul MD; Gedam M; Pasquale EB; Hristova K
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):31-38. PubMed ID: 27776928
[TBL] [Abstract][Full Text] [Related]
18. HER2 Transmembrane Domain Dimerization Coupled with Self-Association of Membrane-Embedded Cytoplasmic Juxtamembrane Regions.
Bragin PE; Mineev KS; Bocharova OV; Volynsky PE; Bocharov EV; Arseniev AS
J Mol Biol; 2016 Jan; 428(1):52-61. PubMed ID: 26585403
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics (MD) investigations of preformed structures of the transmembrane domain of the oncogenic Neu receptor dimer in a DMPC bilayer.
Aller P; Voiry L; Garnier N; Genest M
Biopolymers; 2005 Mar; 77(4):184-97. PubMed ID: 15660449
[TBL] [Abstract][Full Text] [Related]
20. An ephrin mimetic peptide that selectively targets the EphA2 receptor.
Koolpe M; Dail M; Pasquale EB
J Biol Chem; 2002 Dec; 277(49):46974-9. PubMed ID: 12351647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
